Department of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Acta Anaesthesiol Scand. 2022 Sep;66(8):910-922. doi: 10.1111/aas.14107. Epub 2022 Jul 7.
Oxygen therapy is a common treatment in the intensive care unit (ICU) with both potentially desirable and undesirable long-term effects. This systematic review aimed to assess the long-term outcomes of lower versus higher oxygenation strategies in adult ICU survivors.
We included randomised clinical trials (RCTs) comparing lower versus higher oxygen supplementation or oxygenation strategies in adults admitted to the ICU. We searched major electronic databases and trial registers. We included all non-mortality long-term outcomes. Prespecified co-primary outcomes were the long-term cognitive function measures, the overall score of any valid health-related quality of life (HRQoL) evaluation, standardised 6-min walk test, and lung diffusion capacity. The protocol was published and prospectively registered in the PROSPERO database (CRD42021223630).
The review included 17 RCTs comprising 6592 patients, and six trials with 825 randomised patients reported one or more outcomes of interest. We observed no difference in cognitive evaluation via Telephone Interview for Cognitive Status (one trial, 409 patients) (mean score: 30.6 ± 4.5 in the lower oxygenation group vs. 30.4 ± 4.3 in the higher oxygenation group). The trial was judged at overall high risk of bias and the certainty of evidence was very low. Any difference was neither observed in HRQoL measured via EuroQol 5 dimensions 5 level questionnaire and EQ Visual Analogue Score (one trial, 499 patients) (mean score: 70.1 ± 22 in the lower oxygenation group vs. 67.6 ± 22.4 in the higher oxygenation group). The trial was judged as having high risk of bias, the certainty of evidence was very low. No trial reported neither the standardised 6-min walk test nor lung diffusion test.
The evidence is very uncertain about the effect of a lower versus a higher oxygenation strategy on both the cognitive function and HRQoL. A lower versus a higher oxygenation strategy may have a little to no effect on both outcomes but the certainty of evidence is very low. No evidence was found for the effects on the standardised 6-min walking test and diffusion capacity test.
氧气疗法是重症监护病房(ICU)中常用的治疗方法,具有潜在的理想和不理想的长期影响。本系统评价旨在评估成人 ICU 幸存者中较低与较高氧合策略的长期结局。
我们纳入了比较成人 ICU 患者接受较低与较高氧补充或氧合策略的随机临床试验(RCT)。我们检索了主要电子数据库和试验登记处。我们纳入了所有非死亡率的长期结局。预先指定的主要结局是长期认知功能测量、任何有效健康相关生活质量(HRQoL)评估的总体评分、标准 6 分钟步行测试和肺扩散能力。该方案已发布,并在 PROSPERO 数据库(CRD42021223630)中进行了前瞻性注册。
该综述纳入了 17 项 RCT,共纳入 6592 名患者,其中 6 项试验(825 名随机患者)报告了一个或多个感兴趣的结局。我们没有观察到通过电话访谈认知状态(一项试验,409 名患者)评估的认知差异(较低氧合组的平均得分:30.6±4.5,较高氧合组的平均得分:30.4±4.3)。该试验被判定为整体高偏倚风险,证据确定性非常低。通过欧洲五维健康量表 5 级问卷和 EQ 视觉模拟评分(一项试验,499 名患者)测量的 HRQoL 也没有观察到任何差异(较低氧合组的平均得分:70.1±22,较高氧合组的平均得分:67.6±22.4)。该试验被判定为高偏倚风险,证据确定性非常低。没有试验报告标准化 6 分钟步行测试或肺扩散测试。
关于较低与较高氧合策略对认知功能和 HRQoL 的影响,证据非常不确定。与较高氧合策略相比,较低氧合策略可能对这两种结局都没有影响,但证据的确定性非常低。没有证据表明对标准化 6 分钟步行测试和扩散能力测试有影响。